March 23, 2016
Louder Than TB: TB Alliance joins health leaders to call attention to burden of childhood TB
Working together, we can give voice to the voiceless March 11, 2016
Phase 1 Clinical Trial of TB Drug Candidate TBA-354 Discontinued
More investment is needed to expand the portfolio of new TB drug candidates January 4, 2016
Phase 1 TBA-354 Placed on Clinical Hold
TB Alliance announced today that it has voluntarily halted further dosing of TBA-354 in the ongoing Multiple Ascending Dose (MAD) Phase 1 study. November 24, 2015
TB Alliance and Partners Announce World’s First Availability of Appropriate, Child-friendly TB Medicines in Correct Doses
October 28, 2015
TB is now the World's Leading Infectious Killer
May 13, 2015
TB Alliance Launches “Nix-TB” Clinical Trial to Test New XDR-TB Treatment
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB March 23, 2015
Australia Grants Support for TB Alliance to Advance New TB Drugs
New funding supports new tools critical for tackling TB in the Asia-Pacific region and around the world March 23, 2015